As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Author(s)

• 

• Sunil V. Rao, MD

  Assistant Professor of Medicine, Duke University Medical Center; Director, Cardiac Catheterization Laboratories, Durham VA Medical Center, Durham, North Carolina

  Disclosures

  Disclosure: Sunil V. Rao, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Lilly; Terumo Medical Corporation; The Medicines Company
  Received grants for clinical research from: Ikaria, Inc.; Sanofi
  
  Dr Rao does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
  
  Dr Rao does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

• 

• James B. Hermiller, MD

  Director, Interventional Cardiology, St. Vincent Hospital, Indianapolis, Indiana

  Disclosures

  Disclosure: James B. Hermiller, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Abbott Laboratories; Boston Scientific; Medtronic, Inc.; St. Jude Medical
  Served as a speaker or a member of a speakers bureau for: Lilly; The Medicines Company
  
  Dr Hermiller does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
  
  Dr Hermiller does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

• Ronald K. Miller, PhD

  Scientific Director, Medscape, LLC

  Disclosures

  Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

Steering Committee

• Deepak L. Bhatt, MD, MPH

  Chief of Cardiology, VA Boston Healthcare System; Senior Physician, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts

  Disclosures

  Disclosure: Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships:
  Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Eisai Inc.; Ethicon, Inc.; Medtronic, Inc.; sanofi-aventis; The Medicines Company; Medtronic, Inc.

• Roberta C. Bogaev, MD

  Assistant Professor of Medicine, Baylor College of Medicine, Houston, Texas; Private Practice Cardiologist, Schnitzler Cardiovascular Consultants, San Antonio, Texas

  Disclosures

  Disclosure: Roberta C. Bogaev, MD, has disclosed no relevant financial relationships.

• Ted E. Feldman, MD

  Professor of Medicine, Northwestern University School of Medicine, Evanston, Illinois

  Disclosures

  Disclosure: Ted E. Feldman, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Abbott Laboratories; Boston Scientific; Coherex Medical, Inc.; Edwards Lifesciences; Intervalve; Daiichi Sankyo, Inc.; Lilly; W.L. Gore & Associates, Inc.
  Served as a speaker or a member of a speakers bureau for: Boston Scientific
  Received grants for clinical research from: Abbott Laboratories; Boston Scientific; Edwards Lifesciences; St. Jude Medical; W.L. Gore & Associates, Inc.

• Jagmeet P. Singh, MD, PhD

  Associate Professor of Medicine, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center, Harvard Medical School, Boston, Massachusetts

  Disclosures

  Disclosure: Jagmeet P. Singh, MD, PhD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: BIOTRONIK; Boston Scientific; Medtronic, Inc.; St. Jude Medical; Sorin Group; CardioInsight Technologies Inc.; Thoratec Corporation
  Served as a speaker or a member of a speakers bureau for: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group
  Received grants for clinical research from: BIOTRONIK; Boston Scientific; St.

CME Reviewer

• Nafeez Zawahir, MD

  CME Clinical Director, Medscape, LLC

  Disclosures

  Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

CE Reviewer

• Laura A. Stokowski, RN, MS

  Nurse Planner, Continuing Professional Education Department, Medscape, LLC

  Disclosures

  Disclosure: Laura A. Stokowski, RN, MS, has disclosed no relevant financial relationships.

Nurse Planner

• Laurie E. Scudder, DNP, NP

  Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

  Disclosures

  Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.